02-034 Warszawa, ul. Wawelska 15B
Rejestracja do COI 22 460 00 09Zamówienia publiczne | BIP | Kontakt | tel. 22 546 20 00

2016-03-17

Jeffrey Gershenwald-Wykład naukowy jednego z najwybitniejszych specjalistów w leczeniu czerniaka

Szanowni Państwo, Serdecznie zapraszamy na wykład naukowy jednego z najwybitniejszych specjalistów w leczeniu czerniaka Jeffrey Gershenwald, MD Anderson w Houston(USA) Wykład odbędzie się w dniu 21 marca w godzinach od 9:30-10:30 w Centrum Onkologii-Instytucie, w auli Prof. T. Koszarowskiego. Z poważaniem Organizatorzy


Jeffrey E. Gershenwald, MD, FACS

Jeffrey E. Gershenwald, MD, FACS, is the Dr. John M. Skibber Professor of Surgery in the Department of Surgical Oncology and a Professor in the Department of Cancer Biology at The University of Texas MD Anderson Cancer Center (MD Anderson) in Houston, Texas. He is also the Medical Director of the MD Anderson Melanoma and Skin Center.  Dr. Gershenwald received his M.D. from Cornell University Medical College, and after completing his general surgery residency at The New York Hospital-Cornell Medical Center, he completed a fellowship in Surgical Oncology at MD Anderson before joining its faculty.  In addition to his active surgical oncology practice focused on the care of patients with melanoma, Dr. Gershenwald’s research focuses on integrated prognostic and predictive modeling in melanoma. He currently co-leads the inaugural MD Anderson Melanoma Moon Shot research program, an ambitious initiative that spans the melanoma continuum from public policy and prevention research initiatives to reduce ultraviolet radiation (UVR) exposure in youth to leveraging our understanding of the molecular and immune underpinnings of melanoma to improve treatment options for patients with early-stage and advanced melanoma. Dr. Gershenwald is a member of the Executive Committee of the American Joint Committee on Cancer (AJCC) and its 8th edition Editorial Board, and Chair of its Melanoma Expert Panel. He serves as a member of the Surgical Oncology Board of the American Board of Surgery. Recently, Dr. Gershenwald co-led the melanoma project of The Cancer Genome Atlas (TCGA) program. He has published more than 195 articles in peer-reviewed journals, as well as more than 100 editorials, abstracts, invited articles, and other publications; for the past 12 years, Dr. Gershenwald has been listed in America’s Best Doctors.

Powrót